5 mg Onglyza Saxagliptin Tablets

₹ 91/Stripe

Strength5 mg
FormTablets
CompositionSaxagliptin
Packaging Size2x14 Tablets
Packaging TypeBox
BrandOnglyza
Prescription/Non prescriptionPrescription
Shelf life12 Months
TreatmentUsed With Proper Diet And Exercise To Treat High Blood Sugar (Glucose) Levels In Patients With Type
AvailabilityIn Stock
Saxagliptin Tablets is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps to prevent serious complications of diabetes like kidney damage and blindness.  

Exports To: United Kingdom | United States Of America | Australia | France | Germany

Find products similar to 5 Mg Onglyza Saxagliptin Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromSurat
ShippingAs per delivery location

Product Image

5 mg Onglyza Saxagliptin Tablets-15 mg Onglyza Saxagliptin Tablets-25 mg Onglyza Saxagliptin Tablets-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
20-12-2021
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Oct 2014
GST
24AEPFS0946A1Z6
Import Export Code (IEC)
AEPFS*****
Exports to
United Kingdom | United States Of America | Australia | France | Germany

Established in the year of 2022, We “Splendid Pharmaceutical are Wholesaler, Trader and Exporter of an Pharmaceutical Tablets, Pharmaceutical Capsules and Pharmaceutical Injections etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Sagar Goyani , whose continual backing and direction have been useful to us for attaining exponential development in the current market